http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_59f6fa99af5895c909f2a55c7605bdc7
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Hayday |
| name | Adrian C. Hayday Adrian C Hayday |
| given-name | Adrian C Adrian C. |
| organization-name | ‡London Research Institute, Cancer Research UK, Lincoln’s Inn Fields; and; §Department of Immunobiology, King’s College School of Medicine, Guy’s Hospital, London, United Kingdom 4Peter Gorer Department of Immunobiology, Guy's King's St. Thomas' School of Medicine, Guy's Hospital, SE1 9RT London, United Kingdom C. A. Mallick-Wood, L. I. Richie, A. C. Hayday, Department of Molecular, Cell, and Developmental Biology and Section of Immunobiology, Yale University, New Haven, CT 06520, USA.; J. M. Lewis and R. E. Tigelaar, Department of Dermatology and Section of Immunobiology, Yale University, New Haven, CT 06511, USA.; M. J. Owen, Imperial Cancer Research Fund, Lincoln's Inn Fields, London WC2A 3PX, UK. ‡Department of Immunology, King’s College London SE1 9RT, United Kingdom; and Department of Immunobiology, Guy’s King’s St. Thomas’ Medical School, King’s College, University of London, London, SE1 9RT, United Kingdom; Immunosurveillance Laboratory, The Francis Crick Institute, London, UK. Imperial Cancer Research Fund, Lincoln's Inn Fields, London WC2A 3PX, United Kingdom Peter Gorer Department of Immunobiology, King's College School of Medicine, Borough Wing, Guy's Hospital, London SE1 9RT, United Kingdom;; London Research Institute, Cancer Research United Kingdom, London WC2A 3PX, United Kingdom;; Biomedical Research Centre of Guy's and St Thomas’ Hospitals at King's College, London SE1 9RT, United Kingdom; and Peter Gorer Department of Immunobiology, King’s College London, London SE1 9RT, United Kingdom;; Immunosurveillance Laboratory, The Francis Crick Institute, London NW11AT, United Kingdom; Peter Gorer Department of Immunobiology, Guy's King's St. Thomas' Medical School, London Research Institute, Cancer Research UK, London WC2A 3LY, United Kingdom;; Peter Gorer Department of Immunobiology, King's College at Guy's Hospital, London SE1 9RT, United Kingdom; and *Peter Gorer Department of Immunobiology, King’s College London, London, United Kingdom; *Peter Gorer Department of Immunobiology, King's College London, London SE1 9RT, United Kingdom;; †National Institute for Health Research, Biomedical Research Centre, King’s Health Partners, Guy’s Hospital, London SE1 9RT, United Kingdom;; ¶Cancer Research UK, London Research Institute, London WC2A 3LY, United Kingdom Department of Molecular Cell and Developmental Biology, Yale University, New Haven, Connecticut,1 and; Department of Immunobiology, GKT School of Medicine, University of London, London,3 United Kingdom *Peter Gorer Department of Immunobiology, King’s College London, London SE1 9RT, United Kingdom;; †The Francis Crick Institute, London NW1 1AT, United Kingdom; Department of Biology, Kline Biology Tower, Yale University, New Haven, CT 06511. Peter Gorer Department of Immunobiology, King's College, London, SE1 9RT, United Kingdom;; Immunosurveillance Laboratory, Francis Crick Institute, London, NW1 1AT, United Kingdom 3Peter Gorer Department of Immunobiology, Guy's King's St. Thomas' School of Medicine, Guy's Hospital, London, United Kingdom SE1 9RT Peter Gorer Department of Immunobiology School of Immunology and Microbial Sciences King's College London UK; National Institute for Health Research (NIHR) Biomedical Research Center (BRC) Guy's and St Thomas’ NHS Foundation Trust and King's College London London UK; Immunosurveillance Laboratory The Francis Crick Institute London UK Department of Molecular Cellular and Developmental Biology, Section of Immunobiology, and Department of Medicine, Yale University (Kline Biology Tower) 219 Prospect Street, New Haven, CT 06520 Department of Experimental Medicine and Pathology, University “La Sapienza,” Viale Regina Elena 324, 00161 Roma, Italy; Department of Experimental Medicine, University of L'Aquila, Via Vetoio-Coppito, 2-67100 L'Aquila, Italy; Tettamanti Research Center, New S. Gerardo's Hospital, University of Milano-Bicocca, 20052 Monza, Italy; Department of Cell and Molecular Biology, Karolinska Institute, S-171 77 Stockholm, Sweden; Department of Immunology, Medical Faculty/University Clinics, D-89070 Ulm,... From the *Department of Immunology, College of Medicine, Jagiellonian University, Krakow, Poland; ‡Section of Allergy and Clinical Immunology, Dept. of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06520-8013; §Department of Biology and Section of Immunobiology, Kline Biology Tower, Yale University, New Haven, Connecticut 06520; and ‖Imperial Cancer Research Foundation, London, England WZCA 3PX 5King's College London, London, United Kingdom.; 7Francis Crick Institute, London, United Kingdom. Department of Biology, Yale University, New Haven, Connecticut 06511 Peter Gorer Department of Immunobiology, Guy's King's St. Thomas' Medical School, King's College, Guy's Hospital, London SE1 9RT, UK. aGuy's King's St. Thomas' Medical School, Guy's Hospital, London Bridge, London SE1 9RT, United Kingdom; dYale University, Department of Molecular, Cell and Developmental Biology, New Haven, CT 06520 ‡Unité de Virologie et Imunologie Moléculaires, Institut National de la Recherche Agronomique, Jouy-en-Josas Cedex, France Peter Gorer Department of Immunobiology, King's College London London UK; Cancer Research UK Cancer Immunotherapy Accelerator London UK; Immunosurveillance Laboratory The Francis Crick Institute London UK 3Peter Gorer Department of Immunobiology, The Medical School of King's College at Guy's and St. Thomas' Hospitals, London, United Kingdom; Peter Gorer Department of Immunobiology, King's College School of Medicine at Guy's Hospital, London SE1 9RT, United Kingdom London Research Institute, Cancer Research UK, London WC2A 3LY, United Kingdom;; The Peter Gorer Department of Immunobiology, King’s College London, Guy’s Hospital, London SE19RT, United Kingdom; |
Incoming Links
Total number of triples: 153.